Last reviewed · How we verify
NCT06712394: IPACK
Knee Osteoarthritis and IPACK
trial testing IPACK in Osteoarthritis, Knee in 120 participants. Not yet recruiting.
1 March 2025
Quick facts
| Lead sponsor | Sakarya University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 January 2025 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 July 2025 |
Drugs / interventions tested
- IPACK — full drug profile →
Conditions studied
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
Sponsor
Sakarya University
Who can join
Adults 50 to 90, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Interspace between the Popliteal Artery and Capsule of the posterior Knee (IPACK) block involves ultrasound-guided local anesthetic infiltration of the space between the popliteal artery and the posterior knee joint capsule. The purpose of the study; To investigate the effectiveness of this block applied to knee osteoarthritis in clinical practice. In this study, patients who underwent IPACK block by the practitioner; Demographic data, medications used, block success, block characteristics and block-related complications will be recorded observationally. Before and after the block procedure, patients' pain was measured with the Numeric Rating Scale (NRS) at 1st and 3rd months, their disability levels were measured with The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire and Short Form-12 (Short Form). Quality of life will be measured with the -SF-12) survey.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06712394
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of IPACK
Trials testing the same drug.
- NCT05985629 — IPACK on Early Pain Scores After ACL Reconstruction · Phase 4 · recruiting
- NCT05303233 — IPACK or Selective Tibial Nerve Block for ACL Reconstruction With an Adductor Canal Block · NA · completed
- NCT04499716 — Quadriblock Versus "IPACK + Femoral Triangle Block + Obturator Nerve Block" in Total Knee Arthroplasty · NA · completed
- NCT04213287 — Multimodal Analgesia Methods in Patients Undergoing IPACK Block in Knee Arthroplasty · NA · unknown
Other recruiting trials for Osteoarthritis, Knee
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
- NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
- NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
- NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting
Other Sakarya University trials
Trials by the same sponsor.
- NCT07467655 — THE EFFECT OF DIGITAL STORYTELLING ON NURSING STUDENTS' NURSING PROCESS EDUCATION · NA · not yet recruiting
- NCT07508579 — Effect of Hypothermia on BIS and PSI Correlation During Cardiopulmonary Bypass · not yet recruiting
- NCT07537335 — Knee Osteoartritis Genicular Nerve RF Ablation vs Alcohol Neurolysis · NA · not yet recruiting
- NCT07533669 — Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients · NA · not yet recruiting
- NCT07487324 — Oxygenation in Posterior Stabilization Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06712394 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sakarya University
- Last refreshed: 2 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06712394.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing